Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter

Molecular Pharmacology

Volumn 76, Issue 5, 2009, Pages 1062-1071

  Eloranta, Jyrki J ^a   Hiller, Christian ^a,b   Häusler, Stephanie ^a   Stieger, Bruno ^a   Kullak Ublick, Gerd A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CARRIER PROTEIN; CELL NUCLEUS RECEPTOR; FOLIC ACID; MESSENGER RNA; PROTON COUPLED FOLATE TRANSPORTER PROTEIN; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; COLECALCIFEROL; PROTON; PROTON COUPLED FOLATE TRANSPORTER; SLC46A1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DUODENUM; EX VIVO STUDY; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTESTINE CELL; MALE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN MOTIF; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CELL STRAIN CACO 2; COMPARATIVE STUDY; GENETICS; INTESTINE ABSORPTION; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CACO-2 CELLS; CHOLECALCIFEROL; FOLIC ACID; HUMANS; INTESTINAL ABSORPTION; MALE; MEMBRANE TRANSPORT PROTEINS; PROTON-COUPLED FOLATE TRANSPORTER; PROTONS; RATS; RATS, WISTAR; RECEPTORS, CALCITRIOL;

EID: 70350440282     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.055392     Document Type: Article

References (38)

1. Ali MM and Vaidya V (2007) Vitamin D and cancer. J Cancer Res Ther 3:225-230.
2. Christakos S, Dhawan P, Liu Y, Peng X, and Porta A (2003) New insights into the mechanisms of vitamin D action. J Cell Biochem 88:695-705. (Pubitemid 36258819)
3. Colnot S, Lambert M, Blin C, Thomasset M, and Perret C (1995) Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2D3- receptor heterodimers with high affinity. Mol Cell Endocrinol 113:89-98.
4. Cross HS, Lipkin M, and Kállay E (2006) Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 136:561-564. (Pubitemid 43363735)
5. Cui M, Klopot A, Jiang Y, and Fleet JC (2009) The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2. J Cell Physiol 218:113-121.
6. Dusso AS, Brown AJ, and Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8-F28.
7. Eichholzer M, Tönz O, and Zimmermann R (2006) Folic acid: a public-health challenge. Lancet 367:1352-1361.
8. Fan J, Liu S, Du Y, Morrison J, Shipman R, and Pang KS (2009) Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer. J Pharmacol Exp Ther 330:389-402.
9. Forman BM, Umesono K, Chen J, and Evans RM (1995) Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
10. Ganapathy V, Smith SB, and Prasad PD (2004) SLC19: the folate/thiamine transporter family. Pflugers Arch 447:641-646.
11. Gascon-Barré M, Demers C, Mirshahi A, Néron S, Zalzal S, and Nanci A (2003) The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37:1034-1042. (Pubitemid 36538680)
12. Gonen N, Bram EE, and Assaraf YG (2008) PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells. Biochem Biophys Res Commun 376:787-792.
13. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH and Whitfield GK (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154 (Suppl):S57-S73. (Pubitemid 27380871)
14. Huang YC, Chen JY, and Hung WC (2004) Vitamin D3 receptor/Sp1 complex is required for the induction of p27Kip1 expression by vitamin D3. Oncogene 23:4856-4861.
15. Ifergan I and Assaraf YG (2008) Molecular mechanisms of adaptation to folate deficiency. Vitam Horm 79:99-143.
16. Inoue K, Nakai Y, Ueda S, Kamigaso S, Ohta KY, Hatakeyama M, Hayashi Y, Otagiri M, and Yuasa H (2008) Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol 294:G660-G668.
17. Kamen B (1997) Folate and antifolate pharmacology. Semin Oncol 24:S18-30-S18-39.
18. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, and Li YC (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294:G208-G216.
19. Lichtenstein GR, Sands BE, and Pazianas M (2006) Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis 12:797-813. (Pubitemid 44253764)
20. Naderi N, Farnood A, Habibi M, Derakhshan F, Balaii H, Motahari Z, Agah MR, Firouzi F, Rad MG, Aghazadeh R, et al. (2008) Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 23:1816-1822.
21. Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, Hayashi Y, and Yuasa H (2007) Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther 322:469-476.
22. Pitkin RM (2007) Folate and neural tube defects. Am J Clin Nutr 85:285S-288S.
23. Podvinec M, Kaufmann MR, Handschin C, and Meyer UA (2002) NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol 16:1269-1279. (Pubitemid 34621075)
24. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, and Goldman ID (2006) Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127:917-928. (Pubitemid 44792250)
25. Qiu A, Min SH, Jansen M, Malhotra U, Tsai E, Cabelof DC, Matherly LH, Zhao R, Akabas MH, and Goldman ID (2007) Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. Am J Physiol Cell Physiol 293:C1669-C1678. (Pubitemid 350085626)
26. Rizzello F, Gionchetti P, Venturi A, Morselli C, and Campieri M (2002) Review article: the management of refractory Crohn's disease. Aliment Pharmacol Ther 16 (Suppl 4):40-47.
27. Saborowski M, Kullak-Ublick GA, and Eloranta JJ (2006) The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha. J Pharmacol Exp Ther 317:778-785.
28. Sanderson P, Stone E, Kim YI, Mathers JC, Kampman E, Downes CS, Muir KR, and Baron JA (2007) Folate and colo-rectal cancer risk. Br J Nutr 98:1299-1304.
29. Simmons JD, Mullighan C, Welsh KI, and Jewell DP (2000) Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47:211-214. (Pubitemid 30489764)
30. Subramanian VS, Marchant JS, and Said HM (2008a) Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia. Am J Physiol Cell Physiol 294:C233-C240.
31. Subramanian VS, Reidling JC, and Said HM (2008b) Differentiation- dependent regulation of the intestinal folate uptake process: studies with Caco-2 cells and native mouse intestine. Am J Physiol Cell Physiol 295:C828-C835.
32. Umapathy NS, Gnana-Prakasam JP, Martin PM, Mysona B, Dun Y, Smith SB, Ganapathy V, and Prasad PD (2007) Cloning and functional characterization of the proton-coupled electrogenic folate transporter and analysis of its expression in retinal cell types. Invest Ophthalmol Vis Sci 48:5299-5305. (Pubitemid 351260944)
33. Unal ES, Zhao R, and Goldman ID (2009) Role of the glutamate 185 residue in proton translocation mediated by the proton-coupled folate transporter SLC46A1. Am J Physiol Cell Physiol 297:C66-C74.
34. Wang Y, Rajgopal A, Goldman ID, and Zhao R (2005) Preservation of folate transport activity with a low-pH optimum in rat IEC-6 intestinal epithelial cell lines that lack reduced folate carrier function. Am J Physiol Cell Physiol 288:C65-C71. (Pubitemid 39658428)
35. Wang Y, Zhao R, and Goldman ID (2004) Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Clin Cancer Res 10:6256-6264. (Pubitemid 39287534)
36. Yuasa H, Inoue K, and Hayashi Y (2009) Molecular and functional characteristics of proton-coupled folate transporter. J Pharm Sci. 98:1608-1616.
37. Zhao R, Gao F, Hanscom M, and Goldman ID (2004) A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier. Clin Cancer Res 10:718-727. (Pubitemid 38180440)
38. Zhao R, Min SH, Qiu A, Sakaris A, Goldberg GL, Sandoval C, Malatack JJ, Rosenblatt DS, and Goldman ID (2007) The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood 110:1147-1152. (Pubitemid 47281410)